ENTA compared with JATT: revenue, margins and what each company keeps, and the suppliers and customers both name

ENTAEnanta Pharmaceuticals Inc

Mkt capRevenueRevenue

JATTJATT II Acquisition Corp.

Mkt capRevenueRevenue

Compare

ENTAEnanta Pharmaceuticals Inc

JATTJATT II Acquisition Corp.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ENTA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±19.1%▼−2.10%×0.11

Q2 FY26±19.0%▼−6.02%×0.32

Q1 FY26±13.1%▲+2.17%×0.17

Nov 18 '25±17.1%▼−3.59%×0.21

JATT

No earnings history for JATT.

= impliedENTA realized, solidJATT realized, hatchedOne scale, both sides: full bar = 20%× = |realized| ÷ impliedSource: market data

ENTAEnanta Pharmaceuticals Inc

10.48· pre 10.47· delayed

Mkt cap$303.8MRevenue$14MQ3 FY26Revenue$67MFY24

JATTJATT II Acquisition Corp.

10.25· pre 10.25· delayed

Pre-marketNov 2 '26delayed

Mkt cap$65.8MRevenue—Revenue—

Compare

Pre-marketNov 2 '26delayed

ENTAEnanta Pharmaceuticals Inc

JATTJATT II Acquisition Corp.

10.48pre 10.47delayed

Price

10.25pre 10.25delayed

$303.8M

Mkt cap

$65.8M

Q3 FY26$14M

Revenue

—

FY24$67M

Revenue

—

ENTA10.48vsJATT10.25Pre-marketNov 2 '26delayed